ASML stock dips as Morgan Stanley cuts rating
Morgan Stanley analysts reduced their rating on ASML Holding (ASML) shares from Overweight to Equal-weight, and cut the price target from €925 to €800, citing “late-cycle dynamics” that could impact the company's earnings growth prospects in 2025 and 2026.
Centessa Pharmaceuticals (CNTA) upgraded to Overweight by Morgan Stanley on promising narcolepsy treatment results, stock up ...
Shares of Morgan Stanley MS shed 0.25% to $99.84 Tuesday, on what proved to be an all-around mixed trading session for the ...
Shares of SK Hynix Inc. plunged, leading peers lower, after Morgan Stanley cut its rating on the Korean memory chipmaker two ...
PepsiCo (NASDAQ:PEP) slipped in early trading on Friday after Morgan Stanley downgraded the food and beverage stock. The firm ...
The tail end of 2024 is seeing a market shift in the stock market as the Federal Reserve has finally signaled that interest ...
Morgan Stanley was fined $2 million by a Massachusetts regulator over stock sales by a First Republic executive in the months ...
The settlement, announced Friday, focuses on the sale of $6.8 million in First Republic stock in 2022 and 2023 by a former ...
We recently compiled a list of Morgan Stanley’s Best Stock Picks: 15 Stocks To Own For 2025. In this article, we are going to ...
Fintel reports that on September 16, 2024, Morgan Stanley upgraded their outlook for Kinder Morgan ( NYSE:KMI) from ...
MercadoLibre (NASDAQ: MELI) stock has gained renewed confidence from Wall Street, with firms like Morgan Stanley and Bank of ...
We recently compiled a list of Morgan Stanley’s Best Stock Picks: 15 Stocks To Own For 2025. In this article, we are going to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback